Total raised
$1.5M
Last: Convertible Debt 2023-04
Stage
Seed
Founded
2020
Headcount
6
HQ
Jerusalem
Sector
Agriculture & Food Technologies
About
Ambrosia Bio has developed a disruptive enzyme technology platform that is used to design superior enzymes capable of converting obesity-promoting industrial sugars into minimal-calorie rare sugars such as Allulose. Ambrosia Bio’s B2B business model will provide the leading sugar and Food & Beverages (e.g., juice) manufacturers the opportunity to meet customer expectations of sugar reduction without affecting the consumption experience. Ambrosia Bio will deliver tailored (Plug and Play) engineering solutions for its partners to meet surging rare sugars such as Allulose demand.
Funding history · 5 rounds · $1.5M total
2023-04
Convertible Debt
$1.0M
2023-03
SAFE
$75K
2023-02
SAFE
$200K
2022-08
SAFE
$50K
2022-03
SAFE
Undisclosed
Sectors & technology
Primary sector
Agriculture & Food Technologies
Sub-sectors
Agriculture & Food TechnologiesFood TechFood Trade & ServicesNovel Food & Ingredients
Technologies
BiologicalsMolecules
Target customers
Industrial ManufacturingAgriculture & FoodProcessed FoodsBeveragesIngredientsFood Retail & Consumption
Business model
B2B
Highlights
1 PatentsVerified
Tags
low-sugar-foodsnovel-ingredientsnatural-active-ingredients